1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502)
    Meeting Abstract

    Sinicrope, F. A.; Ou, F. S.; Zemla, T.; Nixon, A. B.; Mody, K.; Levasseur, A.; Dueck, A. C.; Dhanarajan, A. R.; Lieu, C. H.; Cohen, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged >= 65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS
    Meeting Abstract

    Shitara, K.; Doi, T.; Hosaka, H.; Thuss-Patience, P. C.; Santoro, A.; Jimenez-Fonseca, P.; Longo, F.; Ozyilkan, O.; Cicin, I.; Park, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Fitness scale-4 item (FS4) to predict six-month postoperative mortality of cancer patients aged 75
    Meeting Abstract

    Shahrokni, A.; Sarraf, S.; Downey, R. J.; Alexander, K.; Korc-Grodzicki, B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Reduced 90-day postoperative mortality through geriatric comanagement after cancer surgery
    Meeting Abstract

    Shahrokni, A.; Tin, A.; Sarraf, S.; Alexander, K.; Kim, S. J.; Yulico, H.; McMillan, S.; Downey, R. J.; Vickers, A.; Korc-Grodzicki, B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Re-evaluating disease-free survival (DFS) as an endpoint versus overall survival (OS) in adjuvant colon cancer (CC) trials with chemotherapy + /- biologics: An updated surrogacy analysis based on 18,886 patients (pts) from the Accent database
    Meeting Abstract

    Shi, Q.; De Gramont, A.; Dixon, J. G.; Yin, J.; Van Cutsem, E.; Taieb, J.; Alberts, S. R.; Wolmark, N.; Schmoll, H. J.; Saltz, L. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Association of pancreatic cancer stem cells with tumor stroma type
    Meeting Abstract

    Sahin, I. H.; Askan, G.; Chou, J. F.; Capanu, M.; Yu, K. H.; Basturk, O.; Iacobuzio-Donahue, C. A.; O'Reilly, E. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Accumulation of active metabolite M-2 predicts overall survival (OS) of chemorefractory metastatic colorectal cancer patients treated with regorafenib (REGO)
    Meeting Abstract

    Rousseau, B.; Boukerma, A. K.; Henriques, J.; Cohen, R.; Lucidarme, O.; Borg, C.; Tournigand, C.; Kim, S. C. H.; Bachet, J. B.; Mazard, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N. P.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J. F.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Ariyan, C. E.; Untch, B. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Park, W.; Wong, W.; Yu, K. H.; Varghese, A. M.; Riaz, N.; Balachandran, V. P.; El Dika, I. H.; Raj, N. P.; Khalil, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save